Group in Medical Technology
Navigation Links
Group in Medical Technology
... the mean percent change in the Forteo(R) group for lumbar spine BMD was 5.5 percent, and for ... months compared with 8.6 percent in the Forteo(R) group and boosted femoral neck BMD by 4.1 percent ... patients enter long-term care, and half of this group never returns to living independently.
...
... August 4 /PRNewswire/ -- Debiopharm group (Debiopharm), a Swiss-based global ... and physical inactivity. About Debiopharm group Debiopharm group is a Swiss-based global ...
... risk of breast cancer." Estrogens are a group of hormones that play a key role in regulating ... found no obvious skin benefits in this particular group of women, another study that looked at women who ... did not wait to start treatment like the other group -- did experience noticeable improvements in ...
... respond to at least one biologic treatment, the group treated with R788 (fostamatinib disodium) did not ... ACR 70 and DAS28 response rates than the placebo group at three months, and therefore, the trial failed ... to placebo. Although the ACR scores for the R788 group were within the expected range in this patient ...
... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... returned to normal. About Debiopharm group Debiopharm group is a Swiss-based global ...
... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... returned to normal. About Debiopharm group Debiopharm group is a Swiss-based global ...
... levels decreased from baseline in the nevirapine group 0.2 mg/dL and increased 28.1 mg/dL in the ATV/r group (p <0.0001). Mean increases in LDL cholesterol were 15 mg/dL in the nevirapine group and 10.5 mg/dL in the ...
... Seattle, WA (a subsidiary of the Transcu group Limited, a company listed on the Singapore ... statistically lower VAS scores for the Active group as compared to the Placebo group. In addition, more than 80% of the Active group reported pain elimination and willingness to ...
... patients of the placebo group, 55.3% of the 120 U group and 46.0% of the 240 U group. AEs reported most ... of the placebo group, in 58.1% of the 120 U group and in 71.0% of the 240 U group. AEs reported ... is the wholly owned, US subsidiary of the Merz group of Companies. A specialty pharmaceutical company, ...
... design (e.g., endpoints, sample size, control group and statistical analyses) is acceptable to ... with only 5 patient (8%) deaths in the orBec(R) group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139). At one year post randomization ...
... in the BTXCo group, and 22.7% in the placebo group reported an adverse event. There were no ... (1.6%) were randomized to the 50 U/mL dilution group (95 patients) or to the 20 U/mL dilution group (97 patients). Limb position (60.4%), Dressing ...
... challenge was significantly lower in the TI+G group (37 vs. 54 mg/dL; p<0.0001). TI+G produced ... with AFRESA than with RAA. Patients in the AFRESA group lost weight (-0.5 +/- 0.3), while patients in the RAA group gained weight (+1.4 +/- 0.3), with the difference ...
... a significantly greater extent in the lorcaserin group than the placebo group at Week 52. "We are pleased to present the ... 5% of baseline body weight in the active-product group is at least 35%, is approximately double the ...
... statistically significantly better in the patient group randomized to Avandia after the average of 5.5 ... rates of CHF in RECORD were higher in the group randomized to Avandia (61 events or 2.7 percent ... bone fractures, which were higher in the group randomized to Avandia and were seen mostly in the ...
... 70-point response was 61 percent in the 500 mg QD group versus 47 percent for placebo (p=0.039). ... to 100-point response was 55 percent in this group versus 40 percent for placebo (p=0.029). In his ... of Severity (CDEIS) was observed in the 500 mg QD group compared to placebo (CDEIS decrease of -8.4 vs. ...
... + placebo were as follows: group SD > 12 ... with results as follows: group Median Overall Survival* % ... in the perifosine + capecitabine patient group is ongoing with 10 of the 20 patients in ...
... 60 days, 3% of patients in the relaxin-30 group had been rehospitalized for heart failure and no ... causes, as compared to 17% in the placebo group (p=0.06), a greater than 80% reduction. After an ... months, no patients in the relaxin-30 group had died of cardiovascular causes, as compared to ...
... capecitabine + placebo were as follows: group N CR PR ORR SD > 12 ... with results as follows: group Median Overall Survival* ... in the perifosine + capecitabine patient group is ongoing with 10 of the 20 patients in this arm ...
... and Zoloft(R) (sertraline), and are among a group of drugs known as CYP2D6 inhibitors. ... but was not limited to antidepressants, and a group of 945 women on tamoxifen who were not taking any ... the cohorts using a CYP2D6 inhibitor and the group on tamoxifen only. The study found that women ...
... -- The Spanish Head and Neck Cancer Cooperative group (TTCC) announced today that Induction ... die from the disease. Head and neck cancer is a group of tumors that mostly arise in the cells that ... is a Spanish non-profit scientific cooperative group fully devoted to head and neck cancer. ...
... agent perifosine was as follows: group N PR SD > 12 wks CBR* ... agent perifosine was as follows: group N PR SD > 12 wks CBR ... (11.7, 33.6)] Three patients out of the group of patients previously treated with and failed ...
... for high-risk neuroblastoma: Children's Oncology group (COG) study ANBL0032 Lead investigator: A. L. Yu, Children's Oncology group Abstract 10067z, Oral Presentation, ... current assumptions and forecasts made by Bayer group management. Various known and unknown risks, ...
... in Europe , according to Millennium Research group WALTHAM, Mass., May 28 /PRNewswire/ -- ... and many more. About Millennium Research group Millennium Research group ( www.MRG.net ), a Decision Resources, Inc. ...
... Sandostatin LAR versus 7.2 months in the placebo group (P<0.0001)(1). The trial, called PROMID ( ... enrolled in the independent Breast International group (BIG) 1-98 study (Femara(R) [letrozole tablets] ... Results from this study revealed that the group of patients receiving Femara had clinically and ...
... decrease in FVC at week 72 in the pirfenidone group than in the placebo group. This magnitude of ... In addition, 40% more patients in the pirfenidone group did not experience a decline in percent predicted ... the ATS meeting data on the low-dose pirfenidone group for the efficacy outcome measures of change in ...
... months for patients in the RISPERDAL(R) CONSTA(R) group and five months for patients in the placebo ... among patients in the RISPERDAL(R) CONSTA(R) group (30 percent; 42/140) compared with the placebo group (56 percent; 76/135). The median dose of ...
... Problem Subscale of the NYPRS-S in the INTUNIV group compared to placebo (-16.0 vs -9.6; P< .001). ... interactions. On the PSI/SF scale, the INTUNIV group reduced its score by 17.0 compared to 7.7 for the placebo group ( P= .002). "These data are testament to ...
Labopharm files New Drug Submission with Health Canada for novel antidepressant
... baseline to the end of the study in the trazodone group versus the placebo group. Statistical ... showed statistical significance in favor of the group administered Labopharm's trazodone. In addition, ... The drop out rate was 21 percent in the placebo group and 30 percent in the trazodone group. In the ...... August 4 /PRNewswire/ -- Debiopharm group (Debiopharm), a Swiss-based global ... and physical inactivity. About Debiopharm group Debiopharm group is a Swiss-based global ...
... risk of breast cancer." Estrogens are a group of hormones that play a key role in regulating ... found no obvious skin benefits in this particular group of women, another study that looked at women who ... did not wait to start treatment like the other group -- did experience noticeable improvements in ...
... respond to at least one biologic treatment, the group treated with R788 (fostamatinib disodium) did not ... ACR 70 and DAS28 response rates than the placebo group at three months, and therefore, the trial failed ... to placebo. Although the ACR scores for the R788 group were within the expected range in this patient ...
... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... returned to normal. About Debiopharm group Debiopharm group is a Swiss-based global ...
... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... returned to normal. About Debiopharm group Debiopharm group is a Swiss-based global ...
... levels decreased from baseline in the nevirapine group 0.2 mg/dL and increased 28.1 mg/dL in the ATV/r group (p <0.0001). Mean increases in LDL cholesterol were 15 mg/dL in the nevirapine group and 10.5 mg/dL in the ...
... Seattle, WA (a subsidiary of the Transcu group Limited, a company listed on the Singapore ... statistically lower VAS scores for the Active group as compared to the Placebo group. In addition, more than 80% of the Active group reported pain elimination and willingness to ...
Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
... Oncology Group, an NCI-sponsored cooperative group headquartered at the University of Michigan . ... Control and Prevention for the Southwest Oncology group and director of the University of ... John Crowley, Ph.D., of the Southwest Oncology group Statistical Center and Charles A. Coltman, M.D., ...Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
... and medically significant conditions in the group vaccinated with Cervarix (R) were similar to the ... who received at least one vaccine dose. This group comprised a diverse population of women including ... is a registered trademark of the GlaxoSmithKline group of companies. Cautionary statement ...Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
... $7.5m Milestones for Both Companies Sosei group Corporation ("Sosei"; TSE Mothers Index: 4565) ... agreement with Novartis Sosei and Vectura group plc concluded a global development ... new products. About Sosei Sosei group is a leading international biopharmaceutical ...Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative
... A Commonwealth Fund case study notes that group Health Cooperative is structured with ... Hill in cooperative structures, pointing to group Health as a "shining example" of the model, while ... create better health care, medical systems like group Health that have pioneered a different approach, ...Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
... a Swiss-based global biopharmaceutical group of companies with a focus on the development of ... also fewer side effects. About Debiopharm group Debiopharm group is a Swiss-based global ...HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens
... in two different types of packaging: one group received their drugs in standard pharmacy vials, while the other group was given the exact same drug in a unit dose ... both groups, OSU researchers found that the group who received their drugs in blister packs with ...Scottsdale Facility to Be First in U.S. to Showcase True REST Technology
... sober and drug-free. None of the control group did so for eight months of follow-up. ... 22 percent of the participants in the floating group were entirely pain-free, and 56 percent ... session, monthly, twice a month or weekly rates. group rates are available upon request. Reservations ...... patients of the placebo group, 55.3% of the 120 U group and 46.0% of the 240 U group. AEs reported most ... of the placebo group, in 58.1% of the 120 U group and in 71.0% of the 240 U group. AEs reported ... is the wholly owned, US subsidiary of the Merz group of Companies. A specialty pharmaceutical company, ...
... design (e.g., endpoints, sample size, control group and statistical analyses) is acceptable to ... with only 5 patient (8%) deaths in the orBec(R) group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139). At one year post randomization ...
... in the BTXCo group, and 22.7% in the placebo group reported an adverse event. There were no ... (1.6%) were randomized to the 50 U/mL dilution group (95 patients) or to the 20 U/mL dilution group (97 patients). Limb position (60.4%), Dressing ...
... challenge was significantly lower in the TI+G group (37 vs. 54 mg/dL; p<0.0001). TI+G produced ... with AFRESA than with RAA. Patients in the AFRESA group lost weight (-0.5 +/- 0.3), while patients in the RAA group gained weight (+1.4 +/- 0.3), with the difference ...
New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar
... a multicenter, randomized, open-label, parallel group study in insulin naive patients. Lantus(R) was ... achieving A1C<7% at week 24 was greater in the group receiving Apidra(R) three times daily (45.1%) versus the group receiving Apidra(R) one time daily (29.7%, ...... a significantly greater extent in the lorcaserin group than the placebo group at Week 52. "We are pleased to present the ... 5% of baseline body weight in the active-product group is at least 35%, is approximately double the ...
... statistically significantly better in the patient group randomized to Avandia after the average of 5.5 ... rates of CHF in RECORD were higher in the group randomized to Avandia (61 events or 2.7 percent ... bone fractures, which were higher in the group randomized to Avandia and were seen mostly in the ...
Top Medical Research Centers Form Velos Advisory Group for Service-Oriented Architecture
... instrumental in establishing a Velos Advisory group for Service-Oriented Architecture (SOA). Five ... and UT Southwestern Medical Center. The Advisory group will collaborate with Velos to create an SOA ... "We are pleased at the formation of this Advisory group and gratified to see institutions of such high ...... 70-point response was 61 percent in the 500 mg QD group versus 47 percent for placebo (p=0.039). ... to 100-point response was 55 percent in this group versus 40 percent for placebo (p=0.029). In his ... of Severity (CDEIS) was observed in the 500 mg QD group compared to placebo (CDEIS decrease of -8.4 vs. ...
... + placebo were as follows: group SD > 12 ... with results as follows: group Median Overall Survival* % ... in the perifosine + capecitabine patient group is ongoing with 10 of the 20 patients in ...
... 60 days, 3% of patients in the relaxin-30 group had been rehospitalized for heart failure and no ... causes, as compared to 17% in the placebo group (p=0.06), a greater than 80% reduction. After an ... months, no patients in the relaxin-30 group had died of cardiovascular causes, as compared to ...
... capecitabine + placebo were as follows: group N CR PR ORR SD > 12 ... with results as follows: group Median Overall Survival* ... in the perifosine + capecitabine patient group is ongoing with 10 of the 20 patients in this arm ...
... and Zoloft(R) (sertraline), and are among a group of drugs known as CYP2D6 inhibitors. ... but was not limited to antidepressants, and a group of 945 women on tamoxifen who were not taking any ... the cohorts using a CYP2D6 inhibitor and the group on tamoxifen only. The study found that women ...
... -- The Spanish Head and Neck Cancer Cooperative group (TTCC) announced today that Induction ... die from the disease. Head and neck cancer is a group of tumors that mostly arise in the cells that ... is a Spanish non-profit scientific cooperative group fully devoted to head and neck cancer. ...
... agent perifosine was as follows: group N PR SD > 12 wks CBR* ... agent perifosine was as follows: group N PR SD > 12 wks CBR ... (11.7, 33.6)] Three patients out of the group of patients previously treated with and failed ...
... for high-risk neuroblastoma: Children's Oncology group (COG) study ANBL0032 Lead investigator: A. L. Yu, Children's Oncology group Abstract 10067z, Oral Presentation, ... current assumptions and forecasts made by Bayer group management. Various known and unknown risks, ...
... in Europe , according to Millennium Research group WALTHAM, Mass., May 28 /PRNewswire/ -- ... and many more. About Millennium Research group Millennium Research group ( www.MRG.net ), a Decision Resources, Inc. ...
... Sandostatin LAR versus 7.2 months in the placebo group (P<0.0001)(1). The trial, called PROMID ( ... enrolled in the independent Breast International group (BIG) 1-98 study (Femara(R) [letrozole tablets] ... Results from this study revealed that the group of patients receiving Femara had clinically and ...
Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
... (median change 0.3 kg for overall lurasidone group vs. 0 kg for placebo) as was its effect on lipid ... (6% and 2% for the overall lurasidone group and placebo, respectively). Adverse events ... six-week study duration for each lurasidone dose group vs. placebo. A key secondary endpoint was the ...First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
... of the Genting Group. Over the years, the Asiatic group had embarked on several significant acquisitions ... in line with its long term strategy, the Asiatic group had, in June 2005, further expanded its ... to develop some 98,300 hectares. The Asiatic group also owns 5 oil mills with a total milling ...... decrease in FVC at week 72 in the pirfenidone group than in the placebo group. This magnitude of ... In addition, 40% more patients in the pirfenidone group did not experience a decline in percent predicted ... the ATS meeting data on the low-dose pirfenidone group for the efficacy outcome measures of change in ...
... months for patients in the RISPERDAL(R) CONSTA(R) group and five months for patients in the placebo ... among patients in the RISPERDAL(R) CONSTA(R) group (30 percent; 42/140) compared with the placebo group (56 percent; 76/135). The median dose of ...
Mutant Genes in High-Risk Childhood Leukemias Identified
... Research Hospital, the Children's Oncology group (COG), the University of New Mexico Cancer ... for a cure. The problem is that this high-risk group is likely a heterogeneous mixture of biologic ... COG, an international clinical trial cooperative group supported by the NCI. Other authors of the ...... Problem Subscale of the NYPRS-S in the INTUNIV group compared to placebo (-16.0 vs -9.6; P< .001). ... interactions. On the PSI/SF scale, the INTUNIV group reduced its score by 17.0 compared to 7.7 for the placebo group ( P= .002). "These data are testament to ...
Other ContentscatheterizationcatheterizationcatheterizationcatheterizationcatheterizationcatheterizationcardiogeniccardiogeniccardiologycardiologycardiologycardiologycardiologytamponadecardiopulmonarycardiopulmonarycardiopulmonarycardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardiovascularcardioversionoiloiloiloiloiloiloiloilOther TagsIDT
(Date:12/14/2009)... Technology Partners, a global software company that automates ... the Pharmaceutical industry, today announced the general availability ... data acquisition platform. The latest release enables quality ... manufacturing processes. ,, MODA 3.0 includes the ... Methods: Each test method in the MODA ...
(Date:12/13/2009)... Scientists have resolved a question about how a ... works using biosensors that reveal previously hidden components ... Although delusions and hallucinations characterize the illness, people ... recall information in a particular order, difficulties that ... or function well, said Lee Schroeder, a student ...
(Date:12/13/2009)... at The Scripps Research Institute have solved a ... an ancient family of enzymes can have two ... to providing guidance for understanding other molecules in ... for the protein,s possible use for combating diseases ... was published in the December 13, 2009 advance, ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes 14401 1Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes 14401 2Breathe Safely LLC 3A Making Respirators 270 25 More Effective 59186 1Breathe Safely LLC 3A Making Respirators 270 25 More Effective 59186 2Patients who received donated pacemakers survive without complications 59182 1Patients who received donated pacemakers survive without complications 59182 2Patients who received donated pacemakers survive without complications 59182 3(Date:12/15/2009)... of Spa, Massage, and Medical tables announces its partnership with ... comfort system to ease pressure felt while laying face down ... ... Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., the premier ... the launch of the Utopian Massage Table with patent pending ...
(Date:12/15/2009)... in the Dec. 15 issue of the Journal ... or obese increases the risk for developing obstructive sleep ... , Results indicate that the risk of ... older increased 3.5 fold with each standard-deviation increase in ... OSA did not significantly increase with increasing BMI among ...
(Date:12/14/2009)... drugs, and more… , ... Santa ... collaboration with scientists at University of Michigan, have developed synthetic ... natural red blood cells, including softness, flexibility, and the ability ... function of natural red blood cells is to carry oxygen, ...
(Date:12/14/2009)... Heska Corporation (Nasdaq: HSKA ; "Heska" ... veterinary diagnostic and specialty products, today announced ... new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the ... ,, Customers receiving these analyzers have invested ... available to the veterinary in-clinic market. ...
(Date:12/14/2009)... 14 Tough Enough To Wear Pink(TM) (TETWP), ... celebrated its fifth anniversary at the signature Tough ... National Finals Rodeo (Wrangler NFR) in Las Vegas. ... rodeo cowboys, the support of the western industry ... crowd sported pink shirts, hats, bracelets and more. ...
Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4[0] Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table[1] Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children[0] Synthetic Red Blood Cells Developed [0] Heska Announces Installation of New Chemistry Analyzer[0] Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary
FluorotrakInstratrakMultisliceIDTTLIFPLIGSEXTANTColcloughSellaLaminectomieMicrodisectomyOSVRickhamSiphonguard
Other Tagsexpanding 2expanding 3expanding 4expanding 5expanding 6expanding 7floor 2floor 3floor 4floor 5teenage 2teenage 3teenage 4teenage 5teenage 6teenage 7teenage 8teenage 9manufactured 2manufactured 3manufactured 4manufactured 5manufactured 6manufactured 7manufactured 8manufactured 9manufactured 10| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |